Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3383245 | Reumatología Clínica | 2010 | 6 Pages |
Abstract
This comparative clinical study in patients with SLE shows that rituximab can be as useful as cyclophosphamide for severe manifestations, maybe showing a faster response. Adverse events were no different. Rituximab should be considered as an adequate alternative for this group of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Lilia Andrade-Ortega, Fedra Irazoque-Palazuelos, Ricardo López-Villanueva, Yaneth Barragán-Navarro, Fernando Bourget-Pietrasanta, Maria de los Ángeles DÃaz-Ceballos, Roberto Hernández-Paz, Adelfia Urenda-Quezada, Rodolfo Rivas-Ruiz,